Revolutionising adjuvants for vaccine development: The engine behind every breakthrough

Croda Pharma’s vaccine specialists will be at booth 413 ready to discuss your projects and challenges. Visit our booth to learn how we are innovating sustainable ingredients to unlock the vaccines of the future. Dr. Dennis Christensen will be presenting on Tuesday 14 October at 14:30, do not miss the chance to hear from the industry renowned thought leader.

Click to download our content:

Tuesday 14 October, 14:30, with Dr. Dennis Christensen

Architects of immunity: Future vaccines using state-of-the-art adjuvants
Formulating vaccines to drive the desired immune response remains a significant challenge. Achieving the right balance of cellular and humoral responses requires adjuvants with well-defined modes of action. From ensuring optimal presentation of the vaccine antigens, to activating pathways that trigger innate immunity, designing vaccines requires rational design and selection of the adjuvant systems. In this presentation, we will explore the scientific considerations of tailoring immune responses and present our CAF^®01and CAF^®09b adjuvant systems as examples of how advanced formulation strategies can address the industry’s challenges. Attendees will gain insight into the mechanisms and applications of these systems in advancing vaccine development, also beyond parenteral delivery. Revolutionising adjuvants for vaccine development, the engine behind every breakthrough.

Find our experts at booth 413

• Dennis Christensen - Head of R&D Adjuvant Systems
• Aia Malik - Business Director Adjuvant Systems
• Angela Kleiner - Head of Insights & Innovation Adjuvant Systems
• Laura Ciccardi - Global Sales Manager
• Alex Kramer - Business Development Manager
• Philip Wroe - Business Development Specialist
• Christos Nikolaou - Country Sales Manager
• Martin Faengewisch - General Sales Manager
• Shawn Hussain - Global Key Account Manager
• Ausra Marciuskaite - Technical Marketing Manager